BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17764005)

  • 1. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.
    Manschot SM; Biessels GJ; de Valk H; Algra A; Rutten GE; van der Grond J; Kappelle LJ;
    Diabetologia; 2007 Nov; 50(11):2388-97. PubMed ID: 17764005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes.
    Manschot SM; Brands AM; van der Grond J; Kessels RP; Algra A; Kappelle LJ; Biessels GJ;
    Diabetes; 2006 Apr; 55(4):1106-13. PubMed ID: 16567535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant functional connectivity of default-mode network in type 2 diabetes patients.
    Cui Y; Jiao Y; Chen HJ; Ding J; Luo B; Peng CY; Ju SH; Teng GJ
    Eur Radiol; 2015 Nov; 25(11):3238-46. PubMed ID: 25903712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.
    Tiehuis AM; Mali WP; van Raamt AF; Visseren FL; Biessels GJ; van Zandvoort MJ; Kappelle LJ; van der Graaf Y;
    J Neurol Sci; 2009 Aug; 283(1-2):170-4. PubMed ID: 19268970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients.
    Manschot SM; Biessels GJ; Rutten GE; Kessels RP; Gispen WH; Kappelle LJ;
    J Neurol Sci; 2008 Jan; 264(1-2):157-62. PubMed ID: 17850822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes.
    Brands AM; Kessels RP; Hoogma RP; Henselmans JM; van der Beek Boter JW; Kappelle LJ; de Haan EH; Biessels GJ
    Diabetes; 2006 Jun; 55(6):1800-6. PubMed ID: 16731845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus.
    van Harten B; Oosterman J; Muslimovic D; van Loon BJ; Scheltens P; Weinstein HC
    Age Ageing; 2007 Mar; 36(2):164-70. PubMed ID: 17350976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of white matter lesions and lacunes on cortical function.
    Reed BR; Eberling JL; Mungas D; Weiner M; Kramer JH; Jagust WJ
    Arch Neurol; 2004 Oct; 61(10):1545-50. PubMed ID: 15477508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes.
    de Bresser J; Reijmer YD; van den Berg E; Breedijk MA; Kappelle LJ; Viergever MA; Biessels GJ;
    Dement Geriatr Cogn Disord; 2010; 30(5):381-6. PubMed ID: 20962529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study.
    Kooistra M; Geerlings MI; van der Graaf Y; Mali WP; Vincken KL; Kappelle LJ; Muller M; Biessels GJ;
    Neurobiol Aging; 2014 Jan; 35(1):35-41. PubMed ID: 23932882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic.
    Biessels GJ; Koffeman A; Scheltens P
    J Neurol; 2006 Apr; 253(4):477-82. PubMed ID: 16283097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications.
    Lobnig BM; Krömeke O; Optenhostert-Porst C; Wolf OT
    Diabet Med; 2006 Jan; 23(1):32-9. PubMed ID: 16409563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia.
    Swartz RH; Stuss DT; Gao F; Black SE
    Stroke; 2008 Mar; 39(3):822-30. PubMed ID: 18258840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study.
    Grool AM; van der Graaf Y; Mali WP; Geerlings MI;
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1093-100. PubMed ID: 21459931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
    Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H
    Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients.
    Anan F; Masaki T; Kikuchi H; Iwao T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
    Diabetes Res Clin Pract; 2010 Feb; 87(2):233-9. PubMed ID: 19931932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.
    Jokinen H; Lipsanen J; Schmidt R; Fazekas F; Gouw AA; van der Flier WM; Barkhof F; Madureira S; Verdelho A; Ferro JM; Wallin A; Pantoni L; Inzitari D; Erkinjuntti T;
    Neurology; 2012 May; 78(22):1785-92. PubMed ID: 22592361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse impact of type 2 diabetes on brain volume in heart failure.
    Alosco ML; Brickman AM; Spitznagel MB; Griffith EY; Narkhede A; Raz N; Cohen R; Sweet LH; Colbert LH; Josephson R; Hughes J; Rosneck J; Gunstad J
    J Clin Exp Neuropsychol; 2013; 35(3):309-18. PubMed ID: 23419083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion.
    Mok V; Wong KK; Xiong Y; Wong A; Schmidt R; Chu W; Hu X; Leung EY; Chen S; Chen Y; Tang WK; Chen X; Ho CL; Wong KS; Wong ST
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):52-7. PubMed ID: 20826875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.